Gastrointestinal Drugs
Prescription drugs and medicines for the gastrointestinal organs and diseases relating to them. This includes any part of the digestive tract from mouth to anus, liver, biliary tract, and the pancreas. Studies in this area include: constipation, Crohn’s disease, diarrhea, gall bladder disease, heartburn, hemorrhoids, Irritable Bowel Syndrome (IBS), ulcers, liver disease, stomach cancer, and more.
The list of FDA approved drugs for gastrointestinal and astroenterology appears below. Click any link to view the full drug information.
For the treatment of symptomatic gastroesophageal reflux disease
For the treatment of advanced pancreatic neuroendocrine tumors
For the treatment Diarrhea caused by Cryptosporidium and Giardia in children.
For the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy
For the treatment of chronic idiopathic constipation
Treatment of ulcerative colitis
For the treatment of metastatic carcinoma of the colon or rectum
Over-the-counter anti-ulcer treatment
For the treatment of active ulcerative proctitis
Generic equivalent of Tagamet Oral Solution
Generic equivalent of Tagamet Oral Solution, 300 mg/5 ml
Generic equivalent of Tagamet HB 200
For the treatment of Crohn?s disease
Treatment for complicated intra-abdominal infections
Mild to moderately active ulcerative colitis
For the treatment of Clostridium difficile-associated diarrhea
For the relief of rheumatoid arthritis and osteoarthritis and prevention of gastric ulcers
For the treatment of Gaucher disease
For the treatment of colon or rectum carcinomas
For the treatment of nausea and vomiting associated with chemotherapy
For the treatment of postoperative ileus
Capsules for the treatment of mild-to-moderate, active Crohn's disease
For the treatment of EGFR-expressing, metastatic colorectal cancer
Contrast agent for magnetic resonance imaging of the gastrointestinal tract
For the treatment of gastrointestinal stromal tumors (GISTs)
For the treatment of chronic hepatitis B in adults with evidence of active viral replication
For the treatment of gastric cancer
For the treatment of genotype 1 chronic hepatitis C
For the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation
Indicated for Irritable Bowel Syndrome (IBS) in females with diarrhea-predominant IBS
Treatment for intra-abdominal infections and bacterial meningitis
For the treatment of gastroesophageal reflux and diabetic gastroparesis
Treatment for vitamin B-12 deficiency
For the eradication of Helicobacter pylori, the healing of erosive esophagitis, and the treatment of symptomatic GERD
Capsules for the treatment of hereditary tyrosinemia type I
For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
For the treatment of exocrine pancreatic insufficiency
For the treatment of chronic hepatitis C who have compensated liver disease
For use in the relief of heartburn associated with acid indigestion and sour stomach
Treatment of heartburn associated with GERD
Treatment for eradication of H. pylori
Treatment for duodenal ulcers
Treatment for gastric ulcers
Treatment for heartburn, gastroesophageal reflux disease (GERD)
Treatment for heartburn
Treatment for duodenal ulcers
Generic equivalent of Compazine
Oral tablets for the treatment of gastroesophageal and pathological hypersecretory conditions
For treatment of erosive esophagitis
For the short-term treatment of gastroesophageal reflux disease
Generic equivalent of Zantac GELdose
Generic equivalent of Zantac
For the treatment of chronic hepatitis C
For the treatment of chronic anal fissure
For the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in pediatrics
For the treatment of chemotherapy-induced nausea and vomiting
To aid in the diagnosis of pancreatic dysfunction and gastrinoma
Treatment for the reduction of scar tissue as a result of abdominal or pelvic surgery
For the treatment of previously treated patients with metastatic colorectal cancer
For the treatment of pancreatic neuroendocrine tumors
For the prevention of hepatitis A and B
For the treatment of complicated skin and skin structure and intra-abdominal infections and bacterial pneumonia
For the maintenance treatment of moderate to severe Crohn?s disease
For the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions
Treatment for primary biliary cirrhosis
For the treatment of chronic hepatitis C genotype 1
For the treatment of arthritis in patients at risk for NSAID-associated ulcers
For the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy
For cleansing of the bowel as a preparation for colonoscopy, in adults 18 years of age and older
Diagnostic contrast agent
For the treatment of metastatic castration-resistant prostate cancer
For the treatment of metastatic colorectal cancer
Treatment for heartburn
For the short-term treatment of irritable bowel syndrome in women whose primary bowel symptom is constipation
For the short-term treatment of irritable bowel syndrome in women whose primary bowel symptom is constipation
For the treatment of pancreatic insufficiency due to cystic fibrosis or other conditions
For the prevention of post-operative, chemotherapy and radiotherapy induced nausea and vomiting
FDA Approved Gastrointestinal Drugs Listings:
The rules of principle for evaluating MediLexicon's FDA gastrointestinal drugs listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.
MediLexicon's FDA Approved Drugs Listings include:
New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.
MediLexicon's FDA Approved Drugs Listings do NOT include:
Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.
The gastrointestinal drugs information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
